Loh, J. J. & Ma, S. Hallmarks of cancer stemness. Cell Stem Cell 31, 617–639 (2024).

Article  CAS  PubMed  Google Scholar 

Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124–1134 (2017).

Article  CAS  PubMed  Google Scholar 

Chu, X. et al. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct. Target. Ther. 9, 170 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tiriac, H. et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov. 8, 1112–1129 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vojnits, K. et al. Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs. Cancer Lett. 599, 217108 (2024).

Article  CAS  PubMed  Google Scholar 

Yang, L. et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct. Target. Ther. 5, 8 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Tarnok, A. Cancer and cytometry. Cytometry A 95, 257–258 (2019).

Article  PubMed  Google Scholar 

Lan, L. & Behrens, A. Are there specific cancer stem cell markers?. Cancer Res. 83, 170–172 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reynolds, B. A. & Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707–1710 (1992).

Article  CAS  PubMed  Google Scholar 

Johnson, S., Chen, H. & Lo, P. K. In vitro tumorsphere formation assays. Bio Protoc. 3, e325 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Loeb, L. A. & Harris, C. C. Advances in chemical carcinogenesis: a historical review and prospective. Cancer Res. 68, 6863–6872 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883–899 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siddiqui, I. A., Sanna, V., Ahmad, N., Sechi, M. & Mukhtar, H. Resveratrol nanoformulation for cancer prevention and therapy. Ann. N. Y. Acad. Sci. 1348, 20–31 (2015).

Article  CAS  PubMed  Google Scholar 

Qureshi-Baig, K., Ullmann, P., Haan, S. & Letellier, E. Tumor-initiating cells: a criTICal review of isolation approaches and new challenges in targeting strategies. Mol. Cancer 16, 40 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Weiswald, L. B., Bellet, D. & Dangles-Marie, V. Spherical cancer models in tumor biology. Neoplasia 17, 1–15 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Li, Y. & Zhang, T. Targeting cancer stem cells by curcumin and clinical applications. Cancer Lett. 346, 197–205 (2014).

Article  CAS  PubMed  Google Scholar 

Manuel Iglesias, J. et al. Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin. PLoS ONE 8, e77281 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555–567 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tanei, T. et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin. Cancer Res. 15, 4234–4241 (2009).

Article  CAS  PubMed  Google Scholar 

Lee, Y., Guan, G. & Bhagat, A. A. ClearCell(R) FX, a label-free microfluidics technology for enrichment of viable circulating tumor cells. Cytometry A 93, 1251–1254 (2018).

Article  PubMed  Google Scholar 

Shirai, K. et al. Hybrid double-spiral microfluidic chip for RBC-lysis-free enrichment of rare cells from whole blood. Lab Chip 22, 4418–4429 (2022).

Article  CAS  PubMed  Google Scholar 

den Hollander, P. et al. Limiting dilution tumor initiation assay: an in vivo approach for the study of cancer stem cells. Methods Mol. Biol. 2429, 547–554 (2022).

Article  Google Scholar 

Bonnay, F. et al. Oxidative metabolism drives immortalization of neural stem cells during tumorigenesis. Cell 182, 1490–1507 (2020).

Article  CAS  PubMed  Google Scholar 

Vlachogiannis, G. et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 359, 920–926 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao, D. et al. Organoid cultures derived from patients with advanced prostate cancer. Cell 159, 176–187 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao, Y. et al. Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer. Cell Stem Cell 26, 17–26 (2020).

Article  CAS  PubMed  Google Scholar 

Chen, P. et al. Patient-derived organoids can guide personalized-therapies for patients with advanced breast cancer. Adv. Sci. 8, e2101176 (2021).

Article  Google Scholar 

Broutier, L. et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat. Med. 23, 1424–1435 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacob, F. et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity. Cell 180, 188–204.e22 (2020).

Article  CAS  PubMed  Google Scholar 

Yin, S. et al. Patient-derived tumor-like cell clusters for drug testing in cancer therapy. Sci. Transl. Med. 12, (2020).

Joensuu, H. et al. Adjuvant capecitabine for early breast cancer: 15-year overall survival results from a randomized trial. J. Clin. Oncol. 40, 1051–1058 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pece, S. et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140, 62–73 (2010).

Article  CAS  PubMed  Google Scholar 

Bushnell, G. G. et al. Natural killer cell regulation of breast cancer stem cells mediates metastatic dormancy. Cancer Res. 84, 3337–3353 (2024).

Article  CAS